Susceptibility to inflammatory bowel diseases promotes invasive carcinomas in a murine model of ATF6-driven colon cancer - Top-Institutions - MDSpire

Susceptibility to inflammatory bowel diseases promotes invasive carcinomas in a murine model of ATF6-driven colon cancer

  • By

  • Janine Kövilein

  • Adam Sorbie

  • Sevana Khaloian

  • Vanessa Küntzel

  • Miriam von Stern

  • Mohamed Ahmed

  • Sebastian Jarosch

  • Marianne Remke

  • Amira Metwaly

  • Elena M Reuss

  • Dirk H Busch

  • Matthieu Allez

  • Katja Steiger

  • Barbara Schraml

  • Olivia I Coleman

  • Dirk Haller

  • July 14, 2025

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Oncology
    • Immunology
    • Microbiome Research

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Gastroenterology
    • Molecular Biology

  • #3

    University of California, San Diego (UCSD) School of Medicine
    University of California, San Diego (UCSD) School of Medicine

    San Diego, CA

    Key Differentiators

    • Gastroenterology
    • Microbiome Research
    • Immunology

  • #4

    Harvard Medical School / Massachusetts General Hospital
    Harvard Medical School / Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Gastroenterology
    • Oncology
    • Molecular Genetics

  • #5

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Gastroenterology
    • Cancer Biology
    • Microbiome Research

Original Source(s)

Susceptibility to inflammatory bowel diseases promotes invasive carcinomas in a murine model of ATF6-driven colon cancer

  • by Janine Kövilein, Adam Sorbie, Sevana Khaloian, Vanessa Küntzel, Miriam von Stern, Mohamed Ahmed, Sebastian Jarosch, Marianne Remke, Amira Metwaly, Elena M Reuss, Dirk H Busch, Matthieu Allez, Katja Steiger, Barbara Schraml, Olivia I Coleman, Dirk Haller

  • July 14, 2025

Related Content

Pregnane X receptor (NR1I2) deficiency in mice reveals context-dependent regulation of inflammatory homeostasis

Antibiotic use and immune-related adverse events in patients treated with immune checkpoint inhibitors: analysis of the FAERS database

Integrase inhibitor–based antiretroviral therapy drives gut microbiota remodeling and immune recovery in HIV infection